CHMP meeting highlights – May 2025
European Pharmaceutical Review
MAY 27, 2025
Generic medicine Emtricitabine/Tenofovir alafenamide Viatris (emtricitabine / tenofovir alafenamide), received a positive opinion to treat adults and adolescents with human immunodeficiency virus type 1 (HIV-1). The CHMP will issue its final recommendations of the medicine in due course.
Let's personalize your content